Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,876
Total Claims
$973K
Drug Cost
263
Beneficiaries
$3,700
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-83%
Opioid rate vs peers
0.7% vs 3.8% avg
+215%
Cost per patient vs peers
$3,700 vs $1,174 avg
+56%
Brand preference vs peers
13.9% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.7%
Opioid Rate
98
Opioid Claims
$2,001
Opioid Cost
17.3%
Long-Acting Rate
Brand vs Generic
Brand: 2,054 claims · $747K
Generic: 12,756 claims · $222K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 358 | $146K |
| Dulaglutide | 102 | $101K |
| Empagliflozin | 136 | $60K |
| Rivaroxaban | 114 | $50K |
| Dapagliflozin Propanediol | 93 | $35K |
| Sitagliptin Phosphate | 91 | $32K |
| Cyclosporine | 52 | $31K |
| Fluticasone/Umeclidin/Vilanter | 42 | $30K |
| Sacubitril/Valsartan | 66 | $25K |
| Mirabegron | 105 | $25K |
| Semaglutide | 18 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 45 | $16K |
| Diclofenac Sodium | 283 | $15K |
| Netarsudil Mesylat/Latanoprost | 36 | $13K |
| Linagliptin | 35 | $13K |
Prescribing Profile
Patient Profile
80
Avg Age
65%
Female
2.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About